Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness via video could keep depression away

NCT ID NCT06832605

Prevention Sponsor: Fundació Sant Joan de Déu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 2 times

Summary

This study tests whether mindfulness-based cognitive therapy (MBCT) delivered through video calls can prevent depression from coming back. 315 adults with recurrent depression in partial remission will be randomly assigned to group MBCT, a self-help manual with minimal video support, or usual care alone. Researchers will track who relapses over 12 months and measure costs, well-being, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness-Based Cognitive Therapy (MBCT) delivered via videoconference
What this could lead to
If successful, this could provide an effective, scalable, and cost-efficient way to prevent depression relapse using remote group therapy or self-help with minimal support.
What could go wrong
This is a behavioral intervention, not a drug, so effects may be modest. The trial is not yet recruiting, and results depend on participant engagement and therapist skill. Remote delivery may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 342 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age over 18. * Diagnosis of recurrent major depressive disorder, with ≥ 2 previous major depressive episodes (MDD), either in an acute mild/moderate episode or in remission. * Internet access (via smartphone or personal computer). * Spanish literacy (spoken and written). Exclusion Criteria: * Current severe depressive episode (≥24 on the GRID-HAMD) * Current or past psychosis, bipolar 1 disorder, a history of schizophrenia, schizoaffective disorder, organic mental disorder, current severe substance abuse, organic brain damage, pervasive developmental delay, persistent antisocial behaviour, recent (in the past 6 months) self-injury requiring clinical management or therapy according to medical records and clinical judgment. * Formal concurrent structured psychotherapy during the intervention period. * No experience in the use of new technologies (smartphones or computers). * Having completed a mindfulness-based structured training and/or extensive meditation experience (i.e., previous participation in meditation retreats (≥1) or regular (≥ weekly) meditation practice) in the previous year, or intending to commence meditation retreats or meditation practice during the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Major depressive disorder, recurrent, in remission are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Depression follicular lymphoma major depressive disorder Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Major depressive disorder, recurrent, in remission Major depressive disorder, recurrent, mild Major depressive disorder, recurrent, moderate

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fundacio Centre Higiene Mental Nou Barris

    RECRUITING

    Barcelona, Barcelona, Spain

  • Hospital General Universitario de Elche

    RECRUITING

    Elche, Alicante, 03203, Spain

  • Hospital Universitario Miguel Servet

    RECRUITING

    Zaragoza, Zaragoza, 50009, Spain

  • Parc Sanitari Sant Joan de Déu (PSSJD)

    RECRUITING

    Sant Boi de Llobregat, Barcelona, 08830, Spain

  • Parc de Salut Mar

    RECRUITING

    Barcelona, Barcelona, 08003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.